Patent intelligence · CA
CA 2648495
FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE
FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE
Patent details — CA 2648495
- Jurisdiction
- CA
- Status
- granted
- Grant date
- Nov 1, 2007
- Expiration
- Oct 27, 2027
- Applicant
- ALPHAPHARM PTY LTD [AU]
- CPC classes
- A61K 9/ 26 A I, A61K/31155, A61K/31437, A61K/314439
Quick answer
CA 2648495 (FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE) is held by ALPHAPHARM PTY LTD [AU]. Status: granted. Granted Nov 1, 2007. Expires Oct 27, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALPHAPHARM PTY LTD [AU]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 26 A I, A61K/31155, A61K/31437, A61K/314439, A61K/314985, A61K/3155
More from ALPHAPHARM PTY LTD [AU]
Related pharmaceutical patents in our USPTO index.
-
CA 2767560
ATOVAQUONE A DIAMETRE DE PARTICULES (D<SB>90</SB>) VARIANT DE PLUS DE 3UM A ENVIRON 10UM
granted -
CA 2765866
FORMULATION PHARMACEUTIQUE
granted -
CA 2712282
COMPOSITION PHARMACEUTIQUE DE DULOXETINE A LIBERATION RETARDEE
granted -
CA 2702664
FORMULATION PHARMACEUTIQUE A LIBERATION CONTROLEE
granted -
WO 2009026621
COMPOSÉ ET COMPOSITION PHARMACEUTIQUES
granted -
CA 2677623
FORME PHARMACEUTIQUE CONTENANT DEUX OU DAVANTAGE DE PRINCIPES ACTIFS PHARMACEUTIQUES SOUS DES FORMES PHYSIQUES DIFFERENTES
granted -
CA 2673419
COMPOSITION PHARMACEUTIQUE
granted -
CA 2673418
COMPOSE ET COMPOSITION PHARMACEUTIQUES
granted
Frequently asked questions
What is US patent 2648495?
CA 2648495 (FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE) is held by ALPHAPHARM PTY LTD [AU]. Status: granted. Granted Nov 1, 2007. Expires Oct 27, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2648495?
ALPHAPHARM PTY LTD [AU] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 12 pharmaceutical patents for this assignee.
When does CA 2648495 expire?
Our index shows an expiration date of Oct 27, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.